U.S. Drugmaker Merck Enters Vaccine Race With 2 New Partnerships

U.S. Drugmaker Merck Enters Vaccine Race With 2 New Partnerships

Assessment

Interactive Video

Health Sciences, Biology

University

Hard

Created by

Quizizz Content

FREE Resource

Merck is joining the race to develop a COVID-19 vaccine, collaborating with nonprofit organizations to create two vaccines. The company aims to leverage its Ebola vaccine technology for one of the COVID-19 vaccines. The US government, led by Health and Human Services Secretary Alex Azar, aims to produce 300 million vaccine doses by 2021. Experts are focusing on which vaccine projects to fund significantly.

Read more

5 questions

Show all answers

1.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What is Merck's strategy in developing a COVID-19 vaccine?

Focusing solely on pandemic preparedness

Collaborating with a nonprofit research organization

Developing a single vaccine independently

Using only existing technology without partnerships

2.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

Which technology is Merck using for its second COVID-19 vaccine?

Technology from their polio vaccine

Newly developed technology

Technology from their Ebola vaccine

Technology from their flu vaccine

3.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What is the goal of the US government regarding COVID-19 vaccine availability?

To make 300 million doses available before 2021

To make 100 million doses available by 2022

To make 500 million doses available by 2023

To make 200 million doses available by 2021

4.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

Who mentioned the US government's goal for vaccine availability?

The President of Merck Research Laboratories

The Secretary of Defense

Health and Human Services Secretary Alex Azar

The Director of the CDC

5.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What are experts focusing on regarding vaccine projects?

Which projects to delay

Which projects to cancel

Which projects to invest in significantly

Which projects to avoid